-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

CAR-T

PhD Trainee
Program: Scientific Workshops @ ASH
Thursday, December 3, 2020: 2:45 PM-3:17 PM
Moderators:
Disclosures:
Olin: Amgen: Consultancy; Genentech: Consultancy; Daiichi Sankyo: Other: Site PI; Astellas: Other: Site PI; Genentech: Other: Site PI; Pfizer: Other: Site PI.
Session Introduction

Rebecca L. Olin, MD

University of California, San Francisco, San Francisco, CA
Senolytic CAR T Cells Reverse Senescence-Associated Pathologies

Judith Feucht, MD

Memorial Sloan Kettering Cancer Center, New York, NY, Germany; University Tuebingen, Tübingen, Germany
Age, Performance Status, and Comorbidities in Relation to IEC-Associated Toxicities (Including ICANS)*

Jordan Gauthier, MD

University of Washington, Seattle Cancer Care Alliance, Seattle, WA; Fred Hutchinson Cancer Research Center, Seattle, WA
Live Q&A and Panel Discussion

Judith Feucht, MD1* and Jordan Gauthier, MD2

1Memorial Sloan Kettering Cancer Center, New York, NY, Germany
2University of Washington, Seattle Cancer Care Alliance, Seattle, WA
See more of: Scientific Workshops @ ASH
<< Previous Session | Next Session >>